All In MedTech

FDA Clearance Tracker · P130008-S010

INSPIRE II UPPER AIRWAY STIMULATION SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 1, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 1, 2016

Approved

Time to decision

63 days

Received Mar 30, 2016. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P130008-S010
Device name
INSPIRE II UPPER AIRWAY STIMULATION SYSTEM
Applicant location
Maple Grove, MN
Received
Mar 30, 2016
Decided
Jun 1, 2016
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P130008

Device type

Device class
Class III

Every decision under product code MNQ

FDA's approval statement

As written in FDA's record.

Approval of the following changes to the post-approval study for the device: revisions to the protocol to increase the enrollment rate.

Source documents

Other decisions for Inspire Medical Systems

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.